Chile - español - ISPC (Instituto de Salud Pública de Chile)

novartis chile s.a. - eltrombopag - sin formulas

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

laboratorios biogenet scc ecuador - eltrombopag 25,0 mg - tableta recubierta - eltrombopag olamina 31,9 mg (equivalente a 25,0 mg de eltrombopag)

Chile - español - ISPC (Instituto de Salud Pública de Chile)

seven pharma chile s.p.a. - eltrombopag olamina - sin formulas

Unión Europea - español - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - púrpura, trombocitopénica, idiopática - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

laboratorios biogenet scc ecuador - eltrombopag 50,0 mg - tableta recubierta - cada tableta recubierta contiene: eltrombopag olamina 63,8 mg (equivalente a 50,0 mg de eltrombopag)

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

remus pharmaceuticals ltd. india - eltrombopag 50mg - tableta recubierta - cada tableta recubierta contiene: eltrombopag olamine 63.8 mg equivalente a 50 mg de eltrombopag ácido libre

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

remus pharmaceuticals ltd. india - eltrombopag 25mg - tableta recubierta - cada tableta recubierta contiene: eltrombopag olamine 31.9 mg equivalente a 25 mg de eltrombopag ácido libre

Venezuela - español - Instituto Nacional de Higiene

novartis de venezuela, s.a. - eltrombopag - tabletas recubiertas - 50 mg

Chile - español - ISPC (Instituto de Salud Pública de Chile)

novartis chile s.a. - eltrombopag - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

novartis chile s.a. - eltrombopag - sin formulas